NSF Webinar: Executing a Successful Remediation Programme
Take part in our webinar on Tuesday 10 December at 3PM London / 10AM New...
The heart of the European Union (EU) regulation of in vitro diagnostic medical devices (IVDs) lies in allowing market access to IVDs that offer clinical benefit, and are safe to the patient, the user of the IVD and others (such as service technicians).
The regulation is written so that requirements ensuring a high level of protection of health and safety are, where appropriate, must be fulfilled.
Under the EU IVD Directive 98 /79 / EC, manufacturers have been required to comply with the essential requirements (ERs).
Take part in our webinar on Tuesday 10 December at 3PM London / 10AM New...
Receive 50% off our pharma and medical devices eLearning, £100 off selected one-day courses and...
Interest in Near Patient Testing (NPT) continues to increase momentum as it has a significant...
Join NSF’s Lynne Byers, Catherine Kay, Howard Broadbridge and Martin Krainz at the CPhI Worldwide...